Fragile X Syndrome

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders

Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome

Parent and Infant Inter(X)Action Intervention (PIXI)

Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)

Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant

A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Early Check: Expanded Screening in Newborns

Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS

Study of SPG601 in Adult Men With Fragile X Syndrome

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders

Speech-in-noise Perception in Autism and Fragile X

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

Physical Activity and Community EmPOWERment Project

A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome

A Trial of Metformin in Individuals With Fragile X Syndrome (Met)

Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS)

Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge

Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome